ai healthcare regulation
50% Fewer Complications with AI Tools vs Manual Dosing
In 2022, the National Academy of Medicine highlighted growing adoption of AI decision-support tools in outpatient diabetes care. AI insulin-dosing systems can dramatically reduce dosing errors, yet relaxed FDA oversight may let less-tested algorithms reach clinics, creating safety trade-offs for clinicians. Financial Disclaimer: This article is for educational purposes only